A New GFP CRISPR for Primary and Non-Dividing Cells

Use of antibiotic resistance markers with CRISPR is an effective tool for cells that proliferate.  However, for primary cells and non-dividing cells, all-in-one sgRNA-Cas9 lentiviral vector that contains a fluorescence marker (GFP-CRISPR) could be a better option.

Our standard, Single-Vector CRISPR-Cas9 System contains a puromycin selection that can be used to isolate transduced cells. In cases where you want to knockout a gene in cytostatic populations, substitution of the puromycin selection for a fluorescent marker enables selection using FACS. Hence, a fluorescent marker such as GFP also allows easy visualization and can expedite your workflow.

Ideally, the most effective approach would be to include both the fluorescent and antibiotic genes in the vector, as we normally do in our shRNA constructs, this design is not an option in our lentiviral based single-vector CRISPR system due to size constraints imposed by the large 4 kb Cas9 nuclease gene, which is required for CRISPR, to be effectively packaged into lentiviral particles. As a result, only one selection marker can be included in Cas9-containing lentiviral vectors.

For genome-wide knockout screens, we recommend using a two-vector CRISPR. With this configuration, both the fluorescent and antibiotic markers are included.

Vector map of the GFP CRISPR construct from Cellecta
Vector map of the GFP CRISPR construct from Cellecta


Leave a comment

Comments will be approved before showing up.


Also in Cellecta Blog & News

Core Population of Cancer Stem Cells Mediates Therapeutic Resistance in Tumors

Researchers at MD Anderson Cancer Center recently used a Cellecta CloneTracker Barcode Library to label patient-derived xenograft (PDX) cells and establish a stable population of aggressive tumorigenic cells with a specific set of barcodes. With this population of barcoded tumorigenic clones, the investigators...
Read More
DriverMap™ Targeted RNA Sequencing of Blood Finds Gene Signatures Linked to Labor

A recent article demonstrates the unique suitability of the DriverMap Expression Profiling Assay for blood biomarker analysis. In Scientific Reports, Tarca, et al. reported that DriverMap Targeted RNA sequencing identified more potential biomarkers associated with spontaneous labor than either standard Illumina...
Read More
Cellecta Scribe™ Vectors Enable RNA-Seq Analysis of Pooled CRISPR and RNAi Screens

Earlier this year, 3 separate studies (Adamson, et al., Datlinger, et al., and Dixit, et al.) demonstrated an approach to combine pooled CRISPR genetic screening with RNA expression profiling at the single-cell level. Integrating these two approaches enables knockout-specific expression data to be generated for...
Read More